- January 2025
- February 2025
- March 2025
- April 2025
- January 2024
- February 2024
- March 2024
- April 2024
- May 2024
- June 2024
- July 2024
- August 2024
- September 2024
- October 2024
- November 2024
- December 2024
- January 2023
- February 2023
- March 2023
- April 2023
- May 2023
- June 2023
- July 2023
- September 2023
- October 2023
- November 2023
- December 2023
- January 2022
- February 2022
- March 2022
- April 2022
- May 2022
- June 2022
- July 2022
- August 2022
- September 2022
- October 2022
- November 2022
- December 2022
- January 2021
- February 2021
- March 2021
- April 2021
- May 2021
- June 2021
- July 2021
- August 2021
- September 2021
- October 2021
- November 2021
- December 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- September 2015
- May 2015
- January 2013
The San Raffaele Neurotech Hub is born in Milan
New perspectives in SPAX5 research: Sephin-1 as a possible therapy
Hypercholesterolemia: a strategy to turn off the defective gene without changing the DNA
Interleukin-2 in patients with depression improves response to treatment
UniSR in the In2Sight project for more sustainable in vivo experimentation
Effective use of markers in Alzheimer’s diagnosis
Gene therapy for ADA-SCID: positive long-term results
Effective gene editing for a rare immunodeficiency affecting the RAG1 gene
UniSR is among the universities that have hosted UniVax Day 2024
0/resolutions/res-c660x528/Finanziamenti_AIRC_2024_UniSR-(1)0.png)
At San Raffaele 17 new research projects supported by the AIRC Foundation
Phacilitate Lifetime Achievement Award 2024 For Advanced Therapies To Luigi Naldini
